|
GB597810A
(en)
|
1943-04-12 |
1948-02-04 |
Gen Printing Ink Corp |
Improvements in or relating to derivatives of diphenyl
|
|
DE1046220B
(de)
|
1956-04-21 |
1958-12-11 |
Bayer Ag |
Verfahren zur Herstellung von Monoazofarbstoffen und deren Metallkomplexverbindungen
|
|
US4119784A
(en)
|
1977-07-01 |
1978-10-10 |
American Cyanamid Company |
Anionic substituted sulfonamido biphenyls
|
|
DE3000519A1
(de)
|
1979-02-01 |
1980-08-14 |
Byk Gulden Lomberg Chem Fab |
Sulfonamido-alkansaeuren, ihre verwendung und herstellung sowie sie enthaltende arzneimittel
|
|
DE3535167A1
(de)
|
1985-10-02 |
1987-04-09 |
Boehringer Mannheim Gmbh |
Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
|
|
IL118325A0
(en)
|
1995-05-25 |
1996-10-31 |
Pont Merck And Pharmaceutical |
Integrin receptor antagonists and pharmaceutical compositions containing them
|
|
WO1997016433A1
(en)
|
1995-10-30 |
1997-05-09 |
Smithkline Beecham Corporation |
Protease inhibitors
|
|
US5760028A
(en)
|
1995-12-22 |
1998-06-02 |
The Dupont Merck Pharmaceutical Company |
Integrin receptor antagonists
|
|
WO1997033887A1
(en)
|
1996-03-15 |
1997-09-18 |
Du Pont Pharmaceuticals Company |
Spirocycle integrin inhibitors
|
|
JP2000515153A
(ja)
|
1996-07-22 |
2000-11-14 |
モンサント カンパニー |
チオールスルホンアミド メタロプロテアーゼインヒビター
|
|
HUP0000641A3
(en)
|
1996-10-16 |
2001-02-28 |
American Cyanamid Company Madi |
Ortho-sulfonamido aryl hydroxamic acid derivatives, their use, as matrix metalloproteinase and tace inhibitors and pharmaceutical compositions containing them
|
|
IL129344A0
(en)
|
1996-11-27 |
2000-02-17 |
Du Pont Pharm Co |
Novel integrin receptor antagonists
|
|
US6214834B1
(en)
|
1997-03-28 |
2001-04-10 |
Dupont Pharmaceuticals Company |
Integrin inhibitor prodrugs
|
|
IL132630A0
(en)
|
1997-05-08 |
2001-03-19 |
Smithkline Beecham Corp |
Protease inhibitors
|
|
DE19719621A1
(de)
|
1997-05-09 |
1998-11-12 |
Hoechst Ag |
Sulfonylaminocarbonsäuren
|
|
PT877019E
(pt)
|
1997-05-09 |
2002-05-31 |
Hoechst Ag |
Acidos diaminocarboxilicos substituidos
|
|
US6291425B1
(en)
|
1999-09-01 |
2001-09-18 |
Guilford Pharmaceuticals Inc. |
Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
|
|
YU47200A
(sh)
|
1998-01-23 |
2002-11-15 |
Aventis Pharma Deutschland Gmbh. |
Novi derivati sulfonamida kao inhibitori koštane resorpcije i kao inhibitori ćelijske adhezije
|
|
JP4750272B2
(ja)
|
1998-02-04 |
2011-08-17 |
ノバルティス アーゲー |
マトリックス分解メタロプロテイナーゼを阻害するスルホニルアミノ誘導体
|
|
JPH11246527A
(ja)
|
1998-03-02 |
1999-09-14 |
Shionogi & Co Ltd |
Ｍｍｐ−８阻害剤
|
|
DE19815547C1
(de)
|
1998-04-07 |
1999-12-02 |
Joachim Schmidt |
Haftmittel für Zahnprothesen
|
|
EP0960882A1
(en)
|
1998-05-19 |
1999-12-01 |
Hoechst Marion Roussel Deutschland GmbH |
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
|
|
MXPA02009309A
(es)
|
2000-03-21 |
2003-03-12 |
Procter & Gamble |
Inhibidores de las metaloproteasas n-sustituidas que contienen cadenas laterales carboxiclicas.
|
|
WO2001090077A1
(en)
|
2000-05-19 |
2001-11-29 |
Guilford Pharmaceuticals, Inc. |
Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
|
|
AU2002228316A1
(en)
|
2001-01-29 |
2002-08-12 |
Insight Strategy And Marketing Ltd |
Carbazole derivatives and their uses as heparanase inhibitors
|
|
JPWO2002074298A1
(ja)
|
2001-03-21 |
2004-07-08 |
小野薬品工業株式会社 |
Ｉｌ−６産生阻害剤
|
|
WO2002089785A1
(en)
|
2001-05-07 |
2002-11-14 |
Smithkline Beecham Corporation |
Sulfonamides
|
|
CN101284773A
(zh)
|
2001-08-09 |
2008-10-15 |
小野药品工业株式会社 |
羧酸衍生物及以它为活性成分的药剂
|
|
GB0126157D0
(en)
|
2001-10-31 |
2002-01-02 |
Univ Aberdeen |
Therapeutic compounds
|
|
US20050227994A1
(en)
|
2002-03-27 |
2005-10-13 |
Shionogi & Co., Ltd. |
Decomposition inhibitor for extracellular matrix of cartilage
|
|
MXPA05002571A
(es)
|
2002-09-04 |
2005-09-08 |
Schering Corp |
Pirazolopirimidinas como inhibidores de cinasa dependientes de ciclina.
|
|
DE10251170A1
(de)
|
2002-10-31 |
2004-05-13 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
|
WO2004073619A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
|
DE602004010514T2
(de)
|
2003-05-07 |
2008-11-27 |
The University Court Of The University Of Aberdeen, Aberdeen |
Ketone und reduzierte ketone als therapeutische mittel zur behandlung von knochenerkrankungen
|
|
JPWO2004106290A1
(ja)
|
2003-05-14 |
2006-07-20 |
キッセイ薬品工業株式会社 |
アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途
|
|
PE20050948A1
(es)
|
2003-09-09 |
2005-12-16 |
Japan Tobacco Inc |
Compuestos de carbamoil-amina como inhibidores de la dipeptidil peptidasa iv
|
|
GB0324792D0
(en)
|
2003-10-23 |
2003-11-26 |
Sterix Ltd |
Compound
|
|
EP1696915A1
(en)
|
2003-12-19 |
2006-09-06 |
Pfizer, Inc. |
Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
|
|
WO2005080367A1
(en)
|
2004-02-12 |
2005-09-01 |
Pharmagene Laboratories Limited |
Ep2 receptor agonists
|
|
GB0405193D0
(en)
|
2004-03-08 |
2004-04-21 |
Medical Res Council |
Compounds
|
|
US20080255240A1
(en)
|
2004-05-05 |
2008-10-16 |
Novo Nordisk A/S |
Sulfonamide Derivatives
|
|
GB0412553D0
(en)
|
2004-06-04 |
2004-07-07 |
Univ Aberdeen |
Therapeutic agents for the treatment of bone conditions
|
|
WO2005123089A2
(en)
|
2004-06-10 |
2005-12-29 |
Kalypsys, Inc. |
Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
|
|
US20090093485A1
(en)
|
2004-10-29 |
2009-04-09 |
Astrazeneca Ab |
Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases
|
|
EP1659113A1
(en)
|
2004-11-08 |
2006-05-24 |
Evotec AG |
Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
|
|
CA2610903A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
N-(pyridin-2-yl)-sulfonamide derivatives
|
|
WO2007008541A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
|
TW200720261A
(en)
|
2005-08-31 |
2007-06-01 |
Sankyo Co |
Phenylene derivatives
|
|
EP1945632B1
(en)
|
2005-11-08 |
2013-09-18 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic modulators of atp-binding cassette transporters
|
|
CA2635531C
(en)
|
2005-12-29 |
2014-06-17 |
Lexicon Pharmaceutical Inc. |
Multicyclic amino acid derivatives and methods of their use
|
|
US7560597B2
(en)
|
2007-03-08 |
2009-07-14 |
The University Court Of The University Of Aberdeen |
2′,4′-dichloro-biphenyl-4-yl-hydroxy-ketones and related compounds and their use as therapeutic agents
|
|
GB0705400D0
(en)
|
2007-03-21 |
2007-05-02 |
Univ Aberdeen |
Therapeutic compounds andm their use
|
|
WO2010025235A1
(en)
|
2008-08-29 |
2010-03-04 |
Regents Of The University Of Michigan |
Selective ligands for the dopamine 3 (d3) receptor and methods of using the same
|
|
TWI453207B
(zh)
|
2008-09-08 |
2014-09-21 |
Signal Pharm Llc |
胺基三唑并吡啶，其組合物及使用其之治療方法
|
|
GB0817208D0
(en)
|
2008-09-19 |
2008-10-29 |
Pimco 2664 Ltd |
Therapeutic apsap compounds and their use
|
|
GB0817207D0
(en)
|
2008-09-19 |
2008-10-29 |
Pimco 2664 Ltd |
therapeutic apsac compounds and their use
|
|
GB201311361D0
(en)
|
2013-06-26 |
2013-08-14 |
Pimco 2664 Ltd |
Compounds and their therapeutic use
|
|
AU2015367528B2
(en)
|
2014-12-17 |
2020-05-14 |
Pimco 2664 Limited |
N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)-benzenesulfonamide compounds and their therapeutic use
|